
The GI tract in the human body presents a host of difficulties when trying to treat cancer.
The study linked and excerpted below states that bromelain and N-acetylcysteine “significantly inhibited cell proliferation...” The study doesn’t say that this supplementation is the best or only therapy available. The study simply reports that these two relatively inexpensive, non-prescription supplements “inhibit cell proliferation.”
Certainly you should consider conventional chemotherapy and or surgery. You need to learn about other forms of anti-oxidant supplements such as curcumin or green tea extract which may integrate with conventional chemotherapy.
I am both a cancer survivor and cancer coach. I was diagnosed with multiple myeloma in ’94 and have been supplementing with Wobenzym N for over 10 years now. The main ingredient in Wobenzym N
is bromelain. Wobenzym N
offers a host of health effects in addition to inhibiting GI cancer cell proliferation.
I recommend Wobenzym N. I take and recommend Now brand N-Acetyl Cysteine
.
For information about anti-oxidant supplementation as cancer therapy scroll down the page, post a question or comment and I will reply ASAP.
Thank you,
Gastrointestinal cancer“ refers to malignant conditions of the gastrointestinal tract (GI tract) and accessory organs of digestion, including the esophagus, stomach, biliary system, pancreas, small intestine, large intestine, rectum and anus.”
” In the present study, the efficacy of bromelain and N-acetylcysteine in single agent and combination treatment of human gastrointestinal carcinoma cells was evaluated in vitro and the underlying mechanisms of effect were explored…
Bromelain and N-acetylcysteine significantly inhibited cell proliferation, more potently in combination therapy. Drug-drug interaction in combination therapy was found to be predominantly synergistic or additive…
We report for the first time to our knowledge the growth-inhibitory and cytotoxic effects of bromelain and N-acetylcysteine, in particular in combination, on a panel of gastrointestinal cancer cell lines with different phenotypes and characteristics. These effects apparently resulted from cell cycle arrest, apoptosis and autophagy…”
Gastrointestinal cancer refers to malignant conditions of the gastrointestinal tract (GI tract) and accessory organs of digestion, including the esophagus, stomach, biliary system, pancreas, small intestine, large intestine, rectum and anus. The symptoms relate to the organ affected and can include obstruction (leading to difficulty swallowing or defecating), abnormal bleeding or other associated problems. The diagnosis often requires endoscopy, followed by biopsy of suspicious tissue. The treatment depends on the location of the tumor, as well as the type of cancer cell and whether it has invaded other tissues or spread elsewhere. These factors also determine the prognosis.
Overall, the GI tract and the accessory organs of digestion (pancreas, liver, gall bladder) are responsible for more cancers and more deaths from cancer than any other system in the body.[1][2] There is significant geographic variation in the rates of different gastrointestinal cancers.[1]